ro 32-0432 has been researched along with serine in 1 studies
Studies (ro 32-0432) | Trials (ro 32-0432) | Recent Studies (post-2010) (ro 32-0432) | Studies (serine) | Trials (serine) | Recent Studies (post-2010) (serine) |
---|---|---|---|---|---|
56 | 0 | 13 | 23,914 | 115 | 6,084 |
Protein | Taxonomy | ro 32-0432 (IC50) | serine (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.015 | |
Cholinesterase | Equus caballus (horse) | 0.016 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayuzawa, R; Doi, C; Kawabata, A; Matsuzuka, T; Nguyen, TA; Pickel, L; Reischman, J; Seiler, G; Tamura, M | 1 |
1 other study(ies) available for ro 32-0432 and serine
Article | Year |
---|---|
C1B domain peptide of protein kinase Cγ significantly suppresses growth of human colon cancer cells in vitro and in an in vivo mouse xenograft model through induction of cell cycle arrest and apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Female; Humans; Indoles; Injections, Intralesional; Isoenzymes; Mice; Mice, SCID; Peptide Fragments; Peptides; Phosphorylation; Protein Interaction Domains and Motifs; Protein Kinase C; Pyrroles; Serine; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2012 |